Genetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer

Associations of ABCB1 and XPC Genetic Polymorphisms with Susceptibility to Colorectal Cancer and Therapeutic Prognosis in a Chinese Population

(2013) Ai-Min Yue et al.   Asian Pacific Journal of Cancer Prevention

The Genotype-Tissue Expression (GTEx) project

(2013) John Lonsdale et al.   NATURE GENETICS

Survival from colorectal cancer in Germany in the early 21st century

(2012) O Majek et al.   BRITISH JOURNAL OF CANCER

Shining a Light on Xeroderma Pigmentosum

(2012) John J. DiGiovanna et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Comprehensive Pathway-Based Association Study of DNA Repair Gene Variants and the Risk of Nasopharyngeal Carcinoma

(2011) H.-D. Qin et al.   CANCER RESEARCH

Genetic variation in nucleotide excision repair pathway genes, pesticide exposure and prostate cancer risk

(2011) Kathryn Hughes Barry et al.   CARCINOGENESIS

DNA repair gene polymorphisms and tobacco smoking in the risk for colorectal adenomas

(2011) Ying Gao et al.   CARCINOGENESIS

ERCC1 and ERCC2 Polymorphisms Predict Clinical Outcomes of Oxaliplatin-Based Chemotherapies in Gastric and Colorectal Cancer: A Systemic Review and Meta-analysis

(2011) Ming Yin et al.   CLINICAL CANCER RESEARCH

Use of the gamma method for self-contained gene-set analysis of SNP data

(2011) Joanna M Biernacka et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Meta-analysis of new genome-wide association studies of colorectal cancer risk

(2011) Ulrike Peters et al.   HUMAN GENETICS

DNA repair genesXPC,XPGpolymorphisms: Relation to the risk of colorectal carcinoma and therapeutic outcome with oxaliplatin-based adjuvant chemotherapy

(2011) Duo Liu et al.   MOLECULAR CARCINOGENESIS

Genetic variability in DNA repair and cell cycle control pathway genes and risk of smoking-related lung cancer

(2011) Shama C. Buch et al.   MOLECULAR CARCINOGENESIS

Age-Specific Administration of Chemotherapy and Long-Term Quality of Life in Stage II and III Colorectal Cancer Patients: A Population-Based Prospective Cohort

(2011) L. Jansen et al.   ONCOLOGIST

MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes

(2010) Yun Li et al.   GENETIC EPIDEMIOLOGY

Pharmacogenetic Predictors of Adverse Events and Response to Chemotherapy in Metastatic Colorectal Cancer: Results From North American Gastrointestinal Intergroup Trial N9741

(2010) Howard L. McLeod et al.   JOURNAL OF CLINICAL ONCOLOGY

Genotype imputation for genome-wide association studies

(2010) Jonathan Marchini et al.   NATURE REVIEWS GENETICS

Multiple genetic polymorphisms in the prediction of clinical outcome of metastatic colorectal cancer patients treated with first-line FOLFOX-4 chemotherapy

(2010) Ming-Yii Huang et al.   Pharmacogenetics and Genomics

Common Genetic Variants and Risk for HPV Persistence and Progression to Cervical Cancer

(2010) Sophia S. Wang et al.   PLoS One

Involvement of drug transporters in the synergistic action of FOLFOX combination chemotherapy

(2009) Dirk Theile et al.   BIOCHEMICAL PHARMACOLOGY

Nucleotide Excision Repair Pathway Polymorphisms and Pancreatic Cancer Risk: Evidence for role of MMS19L

(2009) R. R. McWilliams et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Novel Susceptibility Loci for Second Primary Tumors/Recurrence in Head and Neck Cancer Patients: Large-Scale Evaluation of Genetic Variants

(2009) X. Wu et al.   Cancer Prevention Research

A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies

(2009) Bryan N. Howie et al.   PLoS Genetics

Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer

(2008) D. Cunningham et al.   ANNALS OF ONCOLOGY